Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference
September 01 2021 - 4:15PM
Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that
Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will
participate in an analyst-led fireside chat at the Morgan Stanley
Virtual 19th Annual Global Healthcare Conference on Tuesday,
September 14, 2021, beginning at 5:00 p.m. Eastern Time.
A live audio webcast of this event can be accessed on the
investor relations section of the Centessa Pharmaceuticals website
at https://investors.centessa.com/events-presentations. Replay
of the webcast will be archived on the Company's website for 90
days following the event.
About Centessa PharmaceuticalsCentessa
Pharmaceuticals plc aims to bring impactful new medicines to
patients by combining the strengths of an asset-centric model with
the benefits of scale and diversification typical of larger R&D
organizations. The asset-centric model refers to a highly
specialized, singular-focused company that is led by a team of
well-recognized subject matter experts. Centessa’s asset-centric
companies’ programs range from discovery-stage to late-stage
development and include diverse therapeutic areas such as oncology,
hematology, immunology/inflammation, neuroscience, hepatology,
pulmonology and nephrology. For more information, visit
www.centessa.com.
Contacts:
Investor
Contact: |
Media
Contacts: |
Jennifer Porcelli, Head of
Investor Relations |
US |
Centessa Pharmaceuticals |
Dan Budwick, 1AB |
jennifer.porcelli@centessa.com |
dan@1abmedia.com |
|
|
|
UK/Greater
Europe |
|
Mary Clark & Shabnam Bashir,
Optimum Strategic Communications |
|
centessa@optimumcomms.com |
|
|
|
Switzerland |
|
Marcus Veith, VEITHing
Spirit |
|
marcus@vspirit.ch |
|
M: +41 79 20 75 111 |
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Sep 2023 to Sep 2024